These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 6378236)
21. Prophylaxis of herpes infections after bone-marrow transplantation by oral acyclovir. Gluckman E; Lotsberg J; Devergie A; Zhao XM; Melo R; Gomez-Morales M; Nebout T; Mazeron MC; Perol Y Lancet; 1983 Sep; 2(8352):706-8. PubMed ID: 6136841 [TBL] [Abstract][Full Text] [Related]
22. Implementation and evaluation of a standardized herpes simplex virus prophylaxis protocol on a leukemia/bone marrow transplant unit. Rayani SA; Nimmo CJ; Frighetto L; Martinusen SM; Nickoloff DM; Reece DE; Jewesson PJ Ann Pharmacother; 1994; 28(7-8):852-6. PubMed ID: 7949499 [TBL] [Abstract][Full Text] [Related]
23. Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects. Bryson YJ; Dillon M; Lovett M; Acuna G; Taylor S; Cherry JD; Johnson BL; Wiesmeier E; Growdon W; Creagh-Kirk T; Keeney R N Engl J Med; 1983 Apr; 308(16):916-21. PubMed ID: 6339923 [TBL] [Abstract][Full Text] [Related]
24. Oral acyclovir suppressive therapy in severe recurrent genital herpes. A double-blind, placebo-controlled cross-over study. Kroon S; Petersen CS; Andersen LP; Rasmussen LP; Vestergaard BF Dan Med Bull; 1989 Jun; 36(3):298-300. PubMed ID: 2666040 [TBL] [Abstract][Full Text] [Related]
29. The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation. Selby PJ; Powles RL; Easton D; Perren TJ; Stolle K; Jameson B; Fiddian AP; Tryhorn Y; Stern H Br J Cancer; 1989 Mar; 59(3):434-8. PubMed ID: 2539180 [TBL] [Abstract][Full Text] [Related]
30. Studies in the prophylaxis of herpes infections in severely immunocompromised patients using acyclovir. Prentice HG; Hann IM Schweiz Med Wochenschr Suppl; 1983; 14():26-9. PubMed ID: 6361988 [TBL] [Abstract][Full Text] [Related]
34. Acyclovir in the prevention of duodenal ulcer recurrence. Rune SJ; Linde J; Bonnevie O; Petersen HD; Bendtsen F; Wandall JH; Gluud C; Eriksen J; Skovbjerg H; Vilien M Gut; 1990 Feb; 31(2):151-2. PubMed ID: 2179067 [TBL] [Abstract][Full Text] [Related]
35. Double-blind, placebo-controlled trial comparing long-term suppressive with short-term oral acyclovir therapy for management of recurrent genital herpes. Mattison HR; Reichman RC; Benedetti J; Bolgiano D; Davis LG; Bailey-Farchione A; Remington M; Winter C; Corey L Am J Med; 1988 Aug; 85(2A):20-5. PubMed ID: 3044086 [TBL] [Abstract][Full Text] [Related]
36. Effectiveness of oral acyclovir prophylaxis in renal transplant recipients. Stoffel M; Squifflet JP; Pirson Y; Lamy M; Alexandre GP Transplant Proc; 1987 Feb; 19(1 Pt 3):2190-3. PubMed ID: 3547919 [No Abstract] [Full Text] [Related]
37. Current status and prospects for oral acyclovir treatment of first episode and recurrent genital herpes simplex virus. Bryson YJ J Antimicrob Chemother; 1983 Sep; 12 Suppl B():61-5. PubMed ID: 6355052 [TBL] [Abstract][Full Text] [Related]
38. Oral acyclovir in acute herpes zoster. McKendrick MW; McGill JI; White JE; Wood MJ Br Med J (Clin Res Ed); 1986 Dec; 293(6561):1529-32. PubMed ID: 3099943 [TBL] [Abstract][Full Text] [Related]
39. Valacyclovir versus acyclovir for HSV prophylaxisin neutropenic patients. Warkentin DI; Epstein JB; Campbell LM; Yip JG; Cox VC; Ransier A; Barnett MJ; Marra F Ann Pharmacother; 2002 Oct; 36(10):1525-31. PubMed ID: 12243600 [TBL] [Abstract][Full Text] [Related]
40. Infections caused by herpes simplex virus in the immunocompromised host: natural history and topical acyclovir therapy. Whitley RJ; Levin M; Barton N; Hershey BJ; Davis G; Keeney RE; Whelchel J; Diethelm AG; Kartus P; Soong SJ J Infect Dis; 1984 Sep; 150(3):323-9. PubMed ID: 6090539 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]